Discover 1,440 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,440
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
for
Neoplasms, Lung
Location: Montreal, Ottawa, Wilson NC, Toronto, Los Angeles CA
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07099898
Phase3, Recruiting
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
for
Malignant Glioma
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 21
Code: NCT05099003
Phase1, Phase2, Recruiting
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
for
Platinum-resistant Ovarian Cancer,
Location: Montreal, Toronto, Pittsburgh PA, Grand Rapids MI,
Sponsor: MacroGenics
Sex: Female
Age: 18+
Code: NCT06730347
Phase2, Recruiting
Acoustics as a Metric of Airway Pressure in Premature Infants Using Bubble Continuous Positive Airway Pressure
for
Preterm Infant
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 0
Code: NCT07060833
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
for
Multiple Sclerosis Spasticity
Location: Foxborough MA, Levis, Montreal, Philadelphia PA, Ottawa,
Sponsor: Celgene
Sex: All
Age: 18 - 70
Code: NCT06782490
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
for
Palmoplantar Pustulosis
Location: Fredericton, Elmhurst NY, Philadelphia PA, Hamilton,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07013201
Phase2, Recruiting
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: St. John's, Westbrook ME, Boston MA, Quebec, Sherbrooke,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06966700
Phase3, Recruiting
Menopur And Rekovelle Combination Study Version 2.0
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
for
Pancreatic Cancer, Pancreatic Adenocarcinoma,
Location: The Bronx NY, New York NY, Montreal, Cooperstown NY,
Sponsor: Alpha Tau Medical LTD.
Sex: All
Age: 18 - 70+
Code: NCT06698458
Recruiting
Spatial Memory Training and Cognitive Function
for
Mild Cognitive Impairment
Location: Verdun
Sponsor: Douglas Mental Health University Institute
Sex: All
Age: 55+
Code: NCT07002996
Recruiting
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
for
Refractory Ventricular Tachycardia
Location: Montreal, Salt Lake City UT
Sponsor: Thermedical, Inc.
Sex: All
Age: 18+
Code: NCT05337241
Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St. John's, Scarborough ME, Boston MA, Providence RI,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase3, Recruiting
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis